Searched for
WATSON PHARMA
Ranbaxy sues Actavis in US to prevent sale of acne genericAbsorica helped Ranbaxy shore up its sales in the US market in the September quarter. The drug commands 19% market share in the US.02 Nov, 2013, 10.10 AM IST- Don’t read too much into today’s market pullback: Sudip Bandyopadhyay, Destimoney SecuritiesSudip Bandyopadhyay, MD & CEO, Destimoney Securities Pvt Ltd, shares his views on the market. Excerpts:10 Apr, 2013, 05.42 PM IST
- Buy Sun Pharma with a target price of Rs 966: KarvyKarvy has maintained its Buy rating, with a price target of Rs 966 on Sun Pharma. The companys’s arm URL Pharma has increased the prices by...04 Apr, 2013, 04.00 AM IST
- Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest growing listThe club of the fastest growing generic companies in the world is dominated by US companies , led by US-based Sagent Pharma, which witnesse...30 Aug, 2012, 08.58 AM IST
- Windfall likely for Ranbaxy Laboratories after FDA says no to Watson PharmaceuticalsThe US drug regulator's refusal to allow Watson Pharma to launch generic version of diabetes drug could mean windfall for Ranbaxy, accordin...17 Aug, 2012, 08.01 AM IST
- Strides Arcolab surges 5% as the company fully redeems its outstanding FCCBsStrides Arcolab shares rose by 5% at Rs 758 as the company said it has fully redemmed its outstanding foreign currency loans worth $80milli...27 Jun, 2012, 01.32 PM IST
- Strides Arcolab sold 94% stake in its subsidiary Ascent Pharma health to Watson PharmaceuticalsArcolab sold 94% stake in its subsidiary Ascent Pharmahealth to Watson Pharmaceuticals for an undisclosed amount.24 Jan, 2012, 05.35 PM IST
- Ranbaxy's party may be spoiled by too many playersWhile Ranbaxy did secure the final approval of the USFDA to launch the generic version of Lipitor on time, there are too many players to sp...02 Dec, 2011, 01.28 PM IST
- Watson Pharma launches Lipitor genericWatson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.01 Dec, 2011, 06.46 AM IST
- Ranbaxy struggling to get approvals for Lipitor; stock downShares of Ranbaxy were trading lower in early trade on Wednesday, following reports that the company is still struggling to get approvals f...30 Nov, 2011, 11.22 AM IST
- Pfizer fights to retain Lipitor market shareThe move is expected to hit Ranbaxy Pharma, which has the exclusive rights to sell the generic version for three months beginning November ...24 Nov, 2011, 02.22 AM IST
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.04 Oct, 2011, 08.05 AM IST
- Sun settles patent row with NovartisSun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute ove...07 Dec, 2007, 01.50 AM IST
- Sun Pharma gets US nod for Novartis' ExelonSun Pharma said it has won a 180-day marketing exclusivity for its version of Novartis' $200-million drug Exelon in the US.26 Oct, 2007, 02.23 AM IST
- Reliance, Cipla in talks for retail pactIf the deal is sealed, Cipla will supply generic pharmaceutical products to Reliance Retail.21 Jul, 2007, 02.45 AM IST
- 3M's pharma sales close to $700mRanbaxy and Wockhardt are said to have lined up for 3M’s pharma business in the US. Both entities are looking to further their global ambit...07 Nov, 2006, 12.10 AM IST
- Matrix deal to trigger M&As in pharma secGlobal majors, Teva, Watson, Barr and Activis are also eyeing mid-sized and large Indian cos.30 Aug, 2006, 10.29 AM IST
Load More
